HB 5028
Limits biennial expenditures from fees, moneys or other revenues, including Miscellaneous Receipts, but excluding lottery funds and federal funds, collected or received by the State Board of Pharmacy.
Jurisdiction
Oregon
Session
2025 Regular Session
At the request of
(at the request of Oregon Department of Administrative Services)
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take actionPublic sentiment
Support
0%
Oppose
100%
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill sets a maximum spending limit for the State Board of Pharmacy for the 2025-2027 biennium. It restricts how the Board can spend money collected through fees, miscellaneous receipts, and other revenues, but specifically excludes lottery funds and federal grants. The bill establishes a specific budget amount of $14,210,412 for the Board’s expenses during this period. An emergency declaration allows the bill to take effect immediately.
Key provisions
- Establishes a maximum spending limit of $14,210,412 for the State Board of Pharmacy.
- Restricts spending to fees, moneys, or other revenues collected by the Board.
- Excludes lottery funds and federal funds from the spending limit.
- Applies to the 2025-2027 biennial period.
- Declares an emergency, allowing the bill to take effect immediately.
Who is affected
- State Board of Pharmacy
- Oregon Department of Administrative Services
- Taxpayers (indirectly, through Board fees)
Notable changes
- Specifies a budget limit for the State Board of Pharmacy's expenditures.
- Clarifies the types of revenue that can be used for spending.
Fiscal impact
The bill establishes a specific budget allocation of $14,210,412 for the State Board of Pharmacy for the 2025-2027 biennium.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Oregon Department of Administrative Services
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
Opponents of the proposed 40% fee increase for pharmacy professional licenses express grave concerns that it would impose an undue financial burden on professionals, exacerbating existing challenges in recruiting and retaining staff, particularly for small, independent pharmacies. Many believe that a tiered fee structure based on income levels or other means could be considered as an alternative solution to ensure the integrity of the licensing system without placing an undue financial strain on licensees. The proposed fee increase would have a negative impact on the pharmacy profession's ability to attract and retain talent, undermine the integrity of the licensing system, and disproportionately affect vulnerable populations, such as those just starting their careers or working in lower-paying positions. Opponents urge caution and careful consideration before making a final decision, hoping that the committee will take a proactive approach to addressing this issue with alternative solutions that prioritize fairness and equity.
Source: Testimony Summaries